Fentanyl Sublingual Spray clinical trials
How each study uses Fentanyl Sublingual Spray is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 2
INSYS Therapeutics Inc (6) · M.D. Anderson Cancer Center (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Fentanyl Sublingual Spray is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Sublingual Fentanyl for the Management of Breakthrough PainTerminatedPhase 2M.D. Anderson Cancer CenterNCT02514252Written as Fentanyl Sublingual Spray (FSS)
- Fentanyl Sublingual Spray for Exercise-Induced Breakthrough DyspneaCompletedPhase 2/3M.D. Anderson Cancer CenterNCT02597478Written as Fentanyl Sublingual Spray
- Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored SettingWithdrawnPhase 3INSYS Therapeutics IncNCT02138409Written as Fentanyl Sublingual Spray (FSS)
- Fentanyl Sublingual Spray in Opioid Naive ParticipantsCompletedPhase 1INSYS Therapeutics IncNCT02641340Written as Fentanyl Sublingual Spray
- Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting ConditionsCompletedNot applicableINSYS Therapeutics IncNCT02138396Written as Fentanyl Sublingual Spray (FSS)
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedPhase 3INSYS Therapeutics IncNCT00538850Written as Fentanyl sublingual spray
- Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer PainCompletedPhase 3INSYS Therapeutics IncNCT00538863Written as Fentanyl sublingual spray
- Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral MucositisCompletedPhase 3INSYS Therapeutics IncNCT00956254Written as Fentanyl sublingual spray